Management and Outcomes of Anti-CD38 Refractory Multiple Myeloma: Recycling of Therapies and Impact of PFS on Subsequent Treatments — Eirini Solia (2024) | RDL Network
Joseph Mıkhael, Joshua Richter, Ravi Vij, Craig E. Cole, Jeffrey A. Zonder, Jonathan L. Kaufman, William Bensinger, Meletios A Dimopoulos, Nikoletta Lendvai, Parameswaran Hari, Enrique M. Ocio, Cristina Gasparetto, Shaji Kumar, Corina Oprea, Marielle Chiron, Claire Brillac, Éric Charpentier, Jesús F. San Miguel, Thomas G. Martin
Discussion(0)
No comments yet. Be the first to comment.